Triumph Capital Management Pfizer Inc Transaction History
Triumph Capital Management
- $300 Million
- Q2 2025
A detailed history of Triumph Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Triumph Capital Management holds 18,102 shares of PFE stock, worth $446,214. This represents 0.15% of its overall portfolio holdings.
Number of Shares
18,102
Previous 8,636
109.61%
Holding current value
$446,214
Previous $218,000
100.92%
% of portfolio
0.15%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding PFE
# of Institutions
3,314Shares Held
3.65BCall Options Held
96.6MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA533MShares$13.1 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.5 Billion0.27% of portfolio
-
State Street Corp Boston, MA296MShares$7.3 Billion0.28% of portfolio
-
Geode Capital Management, LLC Boston, MA127MShares$3.14 Billion0.22% of portfolio
-
Norges Bank Oslo, Q893.7MShares$2.31 Billion0.29% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $138B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...